Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Connor

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
ACS Chemical Neuroscience|April 11, 2022
Defining Steric Requirements at CB<sub>1</sub> and CB<sub>2</sub> Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their AnaloguesJack Markham, Eric Sparkes, Rochelle Boyd, et al.
ACS Chemical Neuroscience|April 20, 2022
Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (Ca<sub>V</sub>3) InhibitorsRichard C Kevin, Somayeh Mirlohi, Jamie J Manning, et al.
Frontiers in Psychiatry|October 17, 2022
Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogsEric Sparkes, Rochelle Boyd, Shuli Chen, et al.
Science Signaling|April 3, 2020
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonistsAlexander Gillis, Arisbel B Gondin, Andrea Kliewer, et al.
Science Advances|July 1, 2022
Risks of mining to salmonid-bearing watershedsChristopher J Sergeant, Erin K Sexton, Jonathan W Moore, et al.
Nature Communications|January 4, 2017
Cannabinoid CB<sub>2</sub> receptor ligand profiling reveals biased signalling and off-target activityMarjolein Soethoudt, Uwe Grether, Jürgen Fingerle, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
ACS Chemical Neuroscience|April 11, 2022
Defining Steric Requirements at CB<sub>1</sub> and CB<sub>2</sub> Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their AnaloguesJack Markham, Eric Sparkes, Rochelle Boyd, et al.
ACS Chemical Neuroscience|April 20, 2022
Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (Ca<sub>V</sub>3) InhibitorsRichard C Kevin, Somayeh Mirlohi, Jamie J Manning, et al.
Frontiers in Psychiatry|October 17, 2022
Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogsEric Sparkes, Rochelle Boyd, Shuli Chen, et al.
Science Signaling|April 3, 2020
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonistsAlexander Gillis, Arisbel B Gondin, Andrea Kliewer, et al.
Science Advances|July 1, 2022
Risks of mining to salmonid-bearing watershedsChristopher J Sergeant, Erin K Sexton, Jonathan W Moore, et al.
Nature Communications|January 4, 2017
Cannabinoid CB<sub>2</sub> receptor ligand profiling reveals biased signalling and off-target activityMarjolein Soethoudt, Uwe Grether, Jürgen Fingerle, et al.
Pageof 11